These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29065338)

  • 1. Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients.
    Haverkamp GL; Loosman WL; Schouten RW; Franssen CF; Kema IP; van Diepen M; Dekker FW; Siegert CE; Honig A
    Gen Hosp Psychiatry; 2018; 50():76-82. PubMed ID: 29065338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients.
    Haverkamp GL; Loosman WL; Franssen CF; Kema IP; van Diepen M; Dekker FW; Honig A; Siegert CE
    Nephrol Dial Transplant; 2017 Jun; 32(6):1040-1047. PubMed ID: 27220752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.
    de Vries LV; Minović I; Franssen CFM; van Faassen M; Sanders JS; Berger SP; Navis G; Kema IP; Bakker SJL
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F475-F486. PubMed ID: 28490533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Associations Between Inflammation and Depressive Symptoms in Chronic Dialysis Patients.
    Haverkamp GLG; Loosman WL; Schouten RW; Franssen CFM; Kema IP; van Diepen M; Dekker FW; Chandie Shaw PK; Smets YFC; Vleming LJ; van Jaarsveld BC; Honig A; Siegert CE
    Psychosom Med; 2019 Jan; 81(1):74-80. PubMed ID: 30371633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation.
    Yilmaz N; Ustundag Y; Kivrak S; Kahvecioglu S; Celik H; Kivrak I; Huysal K
    Ren Fail; 2016 Sep; 38(8):1300-9. PubMed ID: 27466137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample.
    Neupane SP; Lien L; Martinez P; Hestad K; Bramness JG
    Alcohol Clin Exp Res; 2015 Mar; 39(3):514-21. PubMed ID: 25639711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise affects symptom severity but not biological measures in depression and somatization - results on IL-6, neopterin, tryptophan, kynurenine and 5-HIAA.
    Hennings A; Schwarz MJ; Riemer S; Stapf TM; Selberdinger VB; Rief W
    Psychiatry Res; 2013 Dec; 210(3):925-33. PubMed ID: 24140252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
    Karu N; McKercher C; Nichols DS; Davies N; Shellie RA; Hilder EF; Jose MD
    BMC Nephrol; 2016 Nov; 17(1):171. PubMed ID: 27832762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy.
    Hol JW; Stolker RJ; Klimek M; Stronks DL; Fekkes D
    J Biomed Sci; 2014 Dec; 21(1):102. PubMed ID: 25526661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
    Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
    Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study.
    Zuo H; Ueland PM; Ulvik A; Eussen SJ; Vollset SE; Nygård O; Midttun Ø; Theofylaktopoulou D; Meyer K; Tell GS
    Am J Epidemiol; 2016 Feb; 183(4):249-58. PubMed ID: 26823439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease.
    Abautret-Daly Á; Dempsey E; Riestra S; de Francisco-García R; Parra-Blanco A; Rodrigo L; Medina C; Connor TJ; Harkin A
    Int J Psychiatry Clin Pract; 2017 Sep; 21(3):221-230. PubMed ID: 28353360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
    Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
    Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients.
    Kato A; Suzuki Y; Suda T; Suzuki M; Fujie M; Takita T; Furuhashi M; Maruyama Y; Chida K; Hishida A
    Hemodial Int; 2010 Oct; 14(4):418-24. PubMed ID: 20673309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.